Quarterly report [Sections 13 or 15(d)]

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)

v3.25.1
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)
9 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Equity [Abstract]    
Number of shares, outstanding, beginning balance | shares 1,605,060 973,400
Weighted average exercise price, outstanding, beginning balance $ 4.85 $ 6.44
Number of shares, granted | shares 1,034,204
Weighted average exercise price, granted $ 3.45
Weighted average grant date fair value, granted $ 2.24
Number of shares, exercised | shares (91,110)
Weighted average exercise price, exercised $ 3.40
Aggregate intrinsic value, exercised | $ $ 86,813
Number of shares, forfeited and cancelled | shares (387,535) (178,459)
Weighted average exercise price, forfeited and cancelled $ 3.39 $ 4.69
Number of shares, outstanding, ending balance | shares 1,217,525 1,738,035
Weighted average exercise price, outstanding, ending balance $ 5.32 $ 5.00
Weighted average remaining contract term stock options outstanding 5 years 4 months 2 days 7 years 11 months 8 days
Aggregate intrinsic value, outstanding | $  
Number of shares, exercisable, ending balance | shares 766,905 497,095
Weighted average exercise price, exercisable, ending balance $ 6.39 $ 8.87
Weighted average remaining contract term stock options exercisable 3 years 7 months 6 days 4 years 6 months 18 days
Aggregate intrinsic value, exercisable | $